In 2003, Fosun Pharma jointly established Sinopharm with the China National Pharmaceutical Group Corporation. Sinopharm is China’s largest pharmaceutical and health care products distributor and leading supply chain service provider.
In 2018, Sinopharm realized revenue of RMB344,500 million, a net profit of RMB9,400 million, and a net profit attributable to shareholders of RMB5,800 million, up 11.73%, 8.53%, and 4.67% respectively from 2017.
At the end of 2018, the number of retail pharmacies owned by Sinopharm amounted to 5,183.
About other business of Fosun Pharma